Clinical history | Intervention group |
---|---|
Coronary heart disease | Formulation 1* |
Cerebrovascular disease | Formulation 2** |
Both or other athero-thrombotic vascular disease | Either Formulation 1* or 2** |
>15% 5-year CVD risk, but without established CVD | Formulation 2** |